These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35390535)

  • 1. Being at work improves stress, craving, and mood for people with opioid use disorder: Ecological momentary assessment during a randomized trial of experimental employment in a contingency-management-based therapeutic workplace.
    Bertz JW; Panlilio LV; Stull SW; Smith KE; Reamer D; Holtyn AF; Toegel F; Kowalczyk WJ; Phillips KA; Epstein DH; Silverman K; Preston KL
    Behav Res Ther; 2022 May; 152():104071. PubMed ID: 35390535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder.
    Preston KL; Kowalczyk WJ; Phillips KA; Jobes ML; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH
    Psychopharmacology (Berl); 2018 Sep; 235(9):2713-2723. PubMed ID: 29980821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.
    Kowalczyk WJ; Moran LM; Bertz JW; Phillips KA; Ghitza UE; Vahabzadeh M; Lin JL; Epstein DH; Preston KL
    Am J Drug Alcohol Abuse; 2018; 44(5):502-511. PubMed ID: 29634425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use.
    Panlilio LV; Stull SW; Bertz JW; Burgess-Hull AJ; Lanza ST; Curtis BL; Phillips KA; Epstein DH; Preston KL
    Psychopharmacology (Berl); 2021 Jun; 238(6):1513-1529. PubMed ID: 33558983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress, craving and mood as predictors of early dropout from opioid agonist therapy.
    Panlilio LV; Stull SW; Kowalczyk WJ; Phillips KA; Schroeder JR; Bertz JW; Vahabzadeh M; Lin JL; Mezghanni M; Nunes EV; Epstein DH; Preston KL
    Drug Alcohol Depend; 2019 Sep; 202():200-208. PubMed ID: 31357121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid-use disorder: an ecological momentary assessment study.
    Mun CJ; Finan PH; Epstein DH; Kowalczyk WJ; Agage D; Letzen JE; Phillips KA; Preston KL
    Addiction; 2021 Jul; 116(7):1794-1804. PubMed ID: 33220102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in daily life stress and craving in opioid-dependent patients.
    Moran LM; Kowalczyk WJ; Phillips KA; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH; Preston KL
    Am J Drug Alcohol Abuse; 2018; 44(5):512-523. PubMed ID: 29641291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid work.
    Bertz JW; Smith KE; Panlilio LV; Stull SW; Reamer D; Murville ML; Sullivan M; Holtyn AF; Toegel F; Epstein DH; Phillips KA; Preston KL
    Drug Alcohol Depend Rep; 2021 Dec; 1():100011. PubMed ID: 36843907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Context and craving during stressful events in the daily lives of drug-dependent patients.
    Preston KL; Kowalczyk WJ; Phillips KA; Jobes ML; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH
    Psychopharmacology (Berl); 2017 Sep; 234(17):2631-2642. PubMed ID: 28593441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial.
    Jarvis BP; Holtyn AF; DeFulio A; Koffarnus MN; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2019 Apr; 197():220-227. PubMed ID: 30852374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.
    Kowalczyk WJ; Phillips KA; Jobes ML; Kennedy AP; Ghitza UE; Agage DA; Schmittner JP; Epstein DH; Preston KL
    Am J Psychiatry; 2015 Aug; 172(8):760-7. PubMed ID: 25783757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.
    Everly JJ; DeFulio A; Koffarnus MN; Leoutsakos JM; Donlin WD; Aklin WM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2011 Jul; 106(7):1309-18. PubMed ID: 21320227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Silverman K
    J Appl Behav Anal; 2014; 47(4):681-93. PubMed ID: 25292399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients.
    Burgess-Hull AJ; Smith KE; Schriefer D; Panlilio LV; Epstein DH; Preston KL
    Drug Alcohol Depend; 2021 Sep; 226():108884. PubMed ID: 34229153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Leoutsakos JM; Silverman K
    Prev Med; 2014 Nov; 68():62-70. PubMed ID: 24607365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with obtaining employment among opioid use disorder patients enrolled in a therapeutic workplace intervention.
    Holtyn AF; Toegel F; Novak MD; Silverman K
    Drug Alcohol Depend; 2021 Sep; 226():108907. PubMed ID: 34311206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial.
    DeFulio A; Everly JJ; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2012 Jan; 120(1-3):48-54. PubMed ID: 21782353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.
    Dunn KE; Defulio A; Everly JJ; Donlin WD; Aklin WM; Nuzzo PA; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Exp Clin Psychopharmacol; 2013 Feb; 21(1):74-83. PubMed ID: 23205722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily temporal patterns of heroin and cocaine use and craving: relationship with business hours regardless of actual employment status.
    Phillips KA; Epstein DH; Preston KL
    Addict Behav; 2013 Oct; 38(10):2485-91. PubMed ID: 23770647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.